Business Description
![Humanigen Inc Humanigen Inc logo](https://static.gurufocus.com/logos/0C00009EVX.png?14)
Humanigen Inc
NAICS : 325412
SIC : 2834
ISIN : US4448631048
Description
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.14 | |||||
9-Day RSI | 45.99 | |||||
14-Day RSI | 45.83 | |||||
6-1 Month Momentum % | 200 | |||||
12-1 Month Momentum % | -99.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -3785.46 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-Forward-EBIT | -0.04 | |||||
EV-to-Forward-EBITDA | -0.04 | |||||
EV-to-Forward-Revenue | 0.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HGENQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humanigen Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.699 | ||
EPS (TTM) ($) | -0.54 | ||
Beta | 0 | ||
Volatility % | 184.85 | ||
14-Day RSI | 45.83 | ||
14-Day ATR ($) | 0.000155 | ||
20-Day SMA ($) | 0.0002 | ||
12-1 Month Momentum % | -99.84 | ||
52-Week Range ($) | 0.00001 - 0.207 | ||
Shares Outstanding (Mil) | 119.08 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Humanigen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Humanigen Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Humanigen Inc Frequently Asked Questions
What is Humanigen Inc(HGENQ)'s stock price today?
The current price of HGENQ is $0.00. The 52 week high of HGENQ is $0.21 and 52 week low is $0.00.
When is next earnings date of Humanigen Inc(HGENQ)?
The next earnings date of Humanigen Inc(HGENQ) is 2024-08-30 Est..
Does Humanigen Inc(HGENQ) pay dividends? If so, how much?
Humanigen Inc(HGENQ) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |